Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CloSYS Oral Rinse for Oral Mucositis in Head and Neck Cancer
NCT03602066Phase 2Terminated
- Sponsor
- University of Arizona
- Start
- Feb 2019
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in oral mucositis (OM) comparing CloSYS Arm with Placebo Arm (2 arms). Primary endpoint: Incidence of Severe Oral Mucositis (WHO Grade >= 3). Started Feb 2019; status: terminated.
02
Drugs
CloSYS Oral Rinse
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03602066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03602066.